Pattern of Bacterial Infections in Paediatric Patients with Chemotherapy-Induced Neutropenia
DOI:
https://doi.org/10.51253/pafmj.v73i6.3602Keywords:
Bacterial infections, Chemotherapy-induced neutropenia, Gram-positive bacteriaAbstract
Objectives: To determine the frequency of bacterial infections and their sensitivity to various antibiotics in paediatric cancer
patients having chemotherapy-induced neutropenia.
Study Design: Cross-sectional study
Place and Duration of Study: Paediatric Oncology ward, Combined Military Hospital, Rawalpindi Pakistan, from Jul 2018 to
Jan 2019.
Methodology: A total of 205 children aged one year to 12 years undergoing chemotherapy and having neutropenic fever were included. Complete history, full physical examination and related blood, microbiological and radiological investigations were undertaken. Antibiotics were given as per protocol.
Results: In our study, the bacterial infections in paediatric cancer patients with chemotherapy-induced neutropenia was found in 45(21.95%) patients. Of these, gram-positive organisms were found in 25(55.5%) patients and gram-negative in 20(44.4%).
Conclusion: The frequency of bacterial infections in paediatric patients with chemotherapy-induced febrile neutropenia is
quite high, with a high percentage of gram-positive bacteria.
Downloads
Metrics
References
Barton CD, Waugh LK, Nielsen MJ, Paulus S. Febrile neutropenia in children treated for malignancy. J Infect 2015 ; 71 (Suppl 1): S27-35. https://doi.org/10.1016/j.jinf.2015.04.026
White L, Ybarra M. Neutropenic fever. Emerg Med Clin NorthAm 2014; 32: 549-561. https://doi.org/10.1016/j.emc.2014.04.002
Mathew VV. Febrile neutropenia. Kerala Nursing Forum 2012;7(1): 5–15.
Biswal S, Godnaik C. Incidence and management of infections inpatients with acute leukemia following chemotherapy in generalwards. Ecancermedicalscience 2013; 7(1): 310-312.https://doi.org/10.3332/ecancer.2013.310.
Lee JH, Kim SK, Kim SK, Han SB, Lee JW, Lee DG, et al. Increasein antibiotic resistant gram negative bacterial infections in febrileneutropenic children. Infect Chemother 2016; 48: 181-189.https://doi.org/10.3947%2Fic.2016.48.3.181
El-Mahallawy HA, Hasaan SS, El-Wakil M, Monseer MM,Shalaby L. Increasing antimicrobial resistance monitored in
surveillance analysis of blood stream infections in febrileneutropenic pediatric oncology patients. Asian Pac J Cancer Prev
; 16(1): 5691-5695.https://doi.org/10.7314/apjcp.2015.16.14.5691
Siddaiahgari S, Manikyam A, Kumar KA, Rauthan A, Aayyar R.Spectrum of systemic bacterial infections during febrile neutropenia in pediatric oncology patients in tertiary care pediatriccentre. Indian J Cancer 2014; 51(1): 403-405.
https://doi.org/10.4103/0019-509x.175367
Mahmud S, Ghafoor T, Badsha S, Gul MS. Bacterial infections inpediatric patients with chemotherapy induced neutropenia. PakMed Assoc 2004; 54(5): 237-244.
Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitativerelationships between circulating leukocytes and infection in
patients with acute leukaemia. Ann Intern Med 1996; 64: 328-340.https://doi.org/10.7326/0003-4819-64-2-328
Leibovici L, Paul M, Cullen M, Bucaneve G, Gafter-Gvilli A,Fraser A, et al. Antibiotic prophylaxis in neutropenic patients :
new evidence, practical decisions. Cancer 2006; 107(1): 1743-1751.https://doi.org/10.1002/cncr.22205
Butt T, Afzal RK, Ahmad RN, Salman M, Mahmood A, AnwarM, et al. Bloodstream infections in febrile neutropenic patients:bacterial spectrum and antimicrobial susceptibility pattern. JAyub Med Coll Abbottabad 2004; 16(1): 18-22.
Gupta S, Bonilla M, Gamero M, Fuentes SL, Caniza M, Sung L, etal. Microbiology and mortality of pediatric febrile neutropenia inEl Salvador. J Pediatr Hematol Oncol 2011; 33(4): 276-280.https://doi.org/10.1097/mph.0b013e31820ff632
Latif SH, Anwar A, Ahmad I. Bacterial pathogens responsible forblood stream infection (BSI) and pattern of drug resistance in atertiary care hospital of Lahore. Biomedica 2009; 25(1): 101-105.
Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A,Gudiol F. Prospective study of 288 episodes of bacteremia inneutropenic cancer patients in a single institution. Eur J ClinMicrobiol Infect Dis 1996; 15(4): 291-296.https://doi.org/10.1007/bf01695660
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Currenttrends in the epidemiology of nosocomial bloodstream infectionsin patients with hematological malignancies and solid neoplasmsin hospitals in the United States. Clin Infect Dis 2003; 36(9): 1103-1110. https://doi.org/10.1086/374339
Paul M, Dickstein Y, Schlesinger A, Grozinsky-Glasberg S,Soares-Weiser K, Leibovici L, et al. Beta-lactam versus β-lactamaminoglycoside combination therapy in cancer patients withneutropenia. Cochrane Database Syst Rev 2013; (6):Cd003038.https://doi.org/10.1002/14651858.cd003038.pub2
Paul M, Yahav D, Bivas A, Fraser A, Leibovici L. Antipseudomonal β-lactams for the initial, empirical, treatment offebrile neutropenia: comparison of β-lactams. Cochrane DatabaseSyst Rev 2010; 11: Cd005197.
https://doi.org/10.1002%2F14651858.CD005197.pub3
Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB,Tack KJ, et al. Efficacy and safety of linezolid compared withvancomycin in a randomized, double-blind study of febrileneutropenic patients with cancer. Clin Infect Dis 2006; 42(1): 597-607. https://doi.org/10.1086/500139
Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A,et al. Survival in neutropenic patients with severe sepsis or septicshock. Crit Care Med 2012; 40(1): 43-49.https://doi.org/10.1097/ccm.0b013e31822b50c2
Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA,Falagas ME. Role of glycopeptides as part of initial empirical
treatment of febrile neutropenic patients: a meta analysis ofrandomized controlled trials. Lancet Infect Dis 2005; 5(7), 431-
https://doi.org/10.1016/s1473-3099(05)70164-x
Al Omar S, Nazer L, Alkayed K. A prospective study of febrileneutropenia in pediatric cancer patients in Jordan. J Pediatr
Hematol Oncol 2013; 35(8): 614-617.https://doi.org/10.1097/mph.0b013e31829f3480
Downloads
Published
How to Cite
Issue
Section
